Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of 6-Day Oral TR-701 Free Acid and 10 Day Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Next Previous
Trial Profile

A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of 6-Day Oral TR-701 Free Acid and 10 Day Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 13 Dec 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tedizolid (Primary) ; Linezolid
  • Indications Gram-positive infections; Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
  • Focus Registrational; Therapeutic Use
  • Acronyms ABSSSI; ESTABLISH-1
  • Sponsors Trius Therapeutics

    • Most Recent Events

    • 01 Dec 2018 Results of post-hoc pooled subgroup analysis of ESTABLISH and ESTABLISH-2 trials (n=1333) assessing efficacy and safety published in the Infectious Diseases and Therapy.
    • 06 Mar 2017 Results of subgroup analysis of pooled efficacy data from two phase III trials (ESTABLISH-1 and ESTABLISH-2) published in the Antimicrobial Agents and Chemotherapy
    • 28 Apr 2015 Results of pooled analysis of ESTABLISH-1 and ESTABLISH-2 trials presented at the 25th European Congress of Clinical Microbiology and Infectious Diseases.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top